Menopausal Disorders Drug Development Market Report: Overview of all products in therapeutic development for each indication

This report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for postmenopausal osteoporosis, vaginal atrophy and vasomotor symptoms of menopause, and features dormant and discontinued products.

Pune, India – July 5, 2018 /MarketersMedia/ —

Vasomotor symptoms of menopause include hot flashes or night sweats that result from sudden opening of the blood vessels close to the skin, usually due to hormonal fluctuations in menopause and perimenopause. These symptoms are caused due to some medications, estrogen withdrawal, thyroid disease, diabetes, hyperhidrosis, anxiety and panic disorders, obesity, hormonally active tumors, chronic infections and neurological disorders. There are 12 products in development for this indication.

Access Report Details at: https://www.themarketreports.com/report/menopausal-disorders-drug-development-pipeline-review-2018

Scope
• Which companies are the most active within each pipeline?
• Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
• To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
• What are the most important R&D milestones and data publications to have happened in this disease area?

Reasons To Buy
• Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
• Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication and a comprehensive picture of recent updates and milestones for each
• Analyze the companies, institutions and universities currently operating in the pipeline and the products being fielded by each of these
• Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Inquire for more details at: https://www.themarketreports.com/report/buy-now/1206008

Companies Mentioned
• Amgen Inc
• EndoCeutics Inc
• Enteris BioPharma Inc
• GL Pharm Tech Corp
• Intas Pharmaceuticals Ltd
• Ipsen SA
• Ligand Pharmaceuticals Inc
• Lupin Ltd
• Luye Pharma Group Ltd
• Medinova AG
• MenoGeniX Inc
• Mithra Pharmaceuticals SA
• NIBEC
• Ogeda SA
• Oncobiologics Inc
• Paras Biopharmaceuticals Finland Oy
• Pherin Pharmaceuticals Inc
• TherapeuticsMD Inc
• Uni-Bio Science Group Ltd

Get this report at: https://www.themarketreports.com/report/ask-your-query/1206008

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/menopausal-disorders-drug-development-market-report-overview-of-all-products-in-therapeutic-development-for-each-indication/372741

For more information, please visit https://www.themarketreports.com/report/menopausal-disorders-drug-development-pipeline-review-2018

Source: MarketersMedia

Release ID: 372741